If drug importation was allowed, nearly 40% of off-patent drugs with limited US competition could have enough competitors to help ensure low prices […]
Author’s perspective
Vinay Prasad on the NCCN’s cancer treatment guidelines: The US system needs an audit
What level of evidence should we have before costly, toxic cancer drugs are given to patients? […]
Treatment or surveillance for CIN2: when less is more
Over the course of a day, a gynaecologist will care for patients with a wide range of presentations—from a premature baby who doesn’t survive beyond the first nights whose young […]
Jay Berry: Unsung heroes of peer review
Think for a moment about all the scientific articles you’ve peer reviewed throughout your career. Do you ever find it challenging to make time to perform the review? Do you […]
Laurie Tomlinson: From patient to data and back again—how anonymised patient records can improve prescribing guidance
We often hear about the importance of “bench to bedside” medicine, how basic science research is translated into novel treatments. But this paper demonstrates an equally important concept: how anonymised […]
Joann Elmore: When diagnostic uncertainty hits home
Joann Elmore discusses how being diagnosed with suspected melanoma altered the focus of her research […]